Letter to NeuroscienceCyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
Section snippets
Acknowledgements
This work was supported by AG13799, AG14239 to GMP, by AG05138 (ADRC of Mount Sinai) to K. L. Davis and by AG02219 (program project) to R. Mohs. The authors thank Drs K. L. Davis, H. Haroutunian, D. Perl and D. P. Purohit (Mount Sinai ADRC) for human brain autopsy material. The authors also thank Dr Jose Freire-Moar for superb technical assistance.
References (22)
- et al.
Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response
Brain Res.
(1995) - et al.
Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease
Neurobiol. Aging
(1996) - et al.
Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor 1β, and tumor necrosis factor α
J. biol. Chem.
(1992) - et al.
TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
J. biol. Chem.
(1991) The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary
Neurobiol. Aging
(1997)Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system
Neurobiol. Aging
(1996)- et al.
Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease
Expl Neurol.
(1997) - et al.
Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids
Neuron
(1993) - et al.
Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation
J. Neurochem.
(1996) - et al.
Inflammatory mechanisms in Alzheimer's disease: implications for therapy
Am. J. Psychiat.
(1994)
β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger
Proc. natn. Acad. Sci. U.S.A.
Cited by (419)
LiuweiDihuang improved cognitive functions in SAMP8 mice by inhibiting COX-2 expression and subsequent neuroinflammation
2022, Journal of EthnopharmacologyMetformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings
2022, Biochemical PharmacologyCitation Excerpt :It has been shown that several inflammatory markers such as TNF, IL-1, and IL-2 rapidly increase the expression of COX-2 [119]. Regarding the association between COX and AD, increased expression of COX-2 is detected in CA1 neurons and frontal cortex that are destined for apoptotic cell death [121,122]. In this case, the effect of metformin on COX-2 activity can be examined in two ways: on one hand, metformin can inhibit the function of the COX-2 enzyme by inhibiting the mentioned cytokines, and on the other hand, it has been stated that metformin suppresses both activity and expression of it in different experimental models [123].
Elevated β-secretase 1 expression mediates CD4<sup>+</sup> T cell dysfunction via PGE2 signalling in Alzheimer's disease
2021, Brain, Behavior, and ImmunityInterrelationship between the 5-lipoxygenase pathway and microbial dysbiosis in the progression of Alzheimer's disease
2021, Biochimica et Biophysica Acta - Molecular and Cell Biology of LipidsA review on mPGES-1 inhibitors: From preclinical studies to clinical applications
2020, Prostaglandins and Other Lipid Mediators